Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Oberweis Micro Cap Institutional OMCIX
- NAV / 1-Day Return 41.07 / −0.39 %
- Total Assets 492.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.280%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield —
- Turnover 58%
USD | NAV as of May 16, 2024 | 1-Day Return as of May 16, 2024, 10:21 PM GMT+0
Morningstar’s Analysis OMCIX
Will OMCIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Umb Ib Money Market Ii | 4.20 | 19.0 Mil | Cash and Equivalents |
Applied Optoelectronics Inc | 3.63 | 16.4 Mil | Technology |
Aehr Test Systems | 3.14 | 14.2 Mil | Technology |
ADMA Biologics Inc | 2.71 | 12.3 Mil | Healthcare |
Camtek Ltd | 2.68 | 12.1 Mil | Technology |
CECO Environmental Corp | 1.92 | 8.7 Mil | Industrials |
Amphastar Pharmaceuticals Inc | 1.87 | 8.4 Mil | Healthcare |
Ultra Clean Holdings Inc | 1.87 | 8.4 Mil | Technology |
TransMedics Group Inc | 1.73 | 7.8 Mil | Healthcare |
Photronics Inc | 1.72 | 7.8 Mil | Technology |